Skip to main content
Top
Published in: Metabolic Brain Disease 2/2014

01-06-2014 | Original Paper

Effects of prenatal methamphetamine exposure: a review of cognitive and neuroimaging studies

Authors: Maja A. Kwiatkowski, Annerine Roos, Dan J. Stein, Kevin G. F. Thomas, Kirsty Donald

Published in: Metabolic Brain Disease | Issue 2/2014

Login to get access

Abstract

Prenatal methamphetamine exposure (PME) is a significant problem in several parts of the world and poses important health risks for the developing fetus. Research on the short- and long-term outcomes of PME is scarce, however. Here, we summarize present knowledge on the cognitive and behavioral outcomes of PME, based on a review of the neuroimaging, neuropsychology, and neuroscience literature published in the past 15 years. Several studies have reported that the behavioral and cognitive sequelae of PME include broad deficits in the domains of attention, memory, and visual-motor integration. Knowledge regarding brain-behavior relationships is poor, however, in large part because imaging studies are rare. Hence, the effects of PME on developing neurocircuitry and brain architecture remain speculative, and are largely deductive. Some studies have implicated the dopamine-rich fronto-striatal pathways; however, cognitive deficits (e.g., impaired visual-motor integration) that should be associated with damage to those pathways are not manifested consistently across studies. We conclude by discussing challenges endemic to research on prenatal drug exposure, and argue that they may account for some of the inconsistencies in the extant research on PME. Studies confirming predicted brain-behavior relationships in PME, and exploring possible mechanisms underlying those relationships, are needed if neuroscience is to address the urgency of this growing public health problem.
Literature
go back to reference Abar B, LaGasse LL, Wouldes T, Derauf C, Newman E, Shah R et al (2013) Cross-national comparison of prenatal methamphetamine exposure on infant and early child physical growth: a natural experiment. Prev Sci 1:1–10 Abar B, LaGasse LL, Wouldes T, Derauf C, Newman E, Shah R et al (2013) Cross-national comparison of prenatal methamphetamine exposure on infant and early child physical growth: a natural experiment. Prev Sci 1:1–10
go back to reference Ahmadlou M, Ahmadi K, Rezazade M, Azad-Marzabadi E (2013) Global organization of functional brain connectivity in methamphetamine abusers. Clin Neurophysiol 124:1122–1131PubMedCrossRef Ahmadlou M, Ahmadi K, Rezazade M, Azad-Marzabadi E (2013) Global organization of functional brain connectivity in methamphetamine abusers. Clin Neurophysiol 124:1122–1131PubMedCrossRef
go back to reference Andersen SL (2003) Trajectories of brain development: point of vulnerability or window of opportunity? Neurosci Biobehav Rev 27:3–18PubMedCrossRef Andersen SL (2003) Trajectories of brain development: point of vulnerability or window of opportunity? Neurosci Biobehav Rev 27:3–18PubMedCrossRef
go back to reference Barr AM, Panenka WJ, MacEwan GW, Thornton AE, Lang DJ, Honer WG, Lecomte T (2006) The need for speed: an update on methamphetamine addiction. J Psychiatry Neurosci 31:301–313PubMedCentralPubMed Barr AM, Panenka WJ, MacEwan GW, Thornton AE, Lang DJ, Honer WG, Lecomte T (2006) The need for speed: an update on methamphetamine addiction. J Psychiatry Neurosci 31:301–313PubMedCentralPubMed
go back to reference Behnke M, Smith VC, Levy S, Ammerman SD, Gonzalez PK, Ryan SA et al (2013) Prenatal substance abuse: short-and long-term effects on the exposed fetus. Pediatrics 131:1009–1024CrossRef Behnke M, Smith VC, Levy S, Ammerman SD, Gonzalez PK, Ryan SA et al (2013) Prenatal substance abuse: short-and long-term effects on the exposed fetus. Pediatrics 131:1009–1024CrossRef
go back to reference Billing L, Eriksson M, Larsson G, Zetterström R (1980) Amphetamine addiction and pregnancy. Acta Paediatr 69:675–680CrossRef Billing L, Eriksson M, Larsson G, Zetterström R (1980) Amphetamine addiction and pregnancy. Acta Paediatr 69:675–680CrossRef
go back to reference Billing L, Eriksson M, Steneroth G, Zetterström R (1988) Predictive indicators for adjustment in 4-year-old children whose mothers used amphetamine during pregnancy. Child Abuse Negl 12:503–507PubMedCrossRef Billing L, Eriksson M, Steneroth G, Zetterström R (1988) Predictive indicators for adjustment in 4-year-old children whose mothers used amphetamine during pregnancy. Child Abuse Negl 12:503–507PubMedCrossRef
go back to reference Billing L, Eriksson M, Jonsson B, Steneroth G, Zetterström R (1994) The influence of environmental factors on behavioural problems in 8-year-old children exposed to amphetamine during fetal life. Child Abuse Negl 18:3–9PubMedCrossRef Billing L, Eriksson M, Jonsson B, Steneroth G, Zetterström R (1994) The influence of environmental factors on behavioural problems in 8-year-old children exposed to amphetamine during fetal life. Child Abuse Negl 18:3–9PubMedCrossRef
go back to reference Brown JM, Hanson GR, Fleckenstein AE (2001) Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants. J Pharmacol Exp Ther 296:762–767PubMed Brown JM, Hanson GR, Fleckenstein AE (2001) Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants. J Pharmacol Exp Ther 296:762–767PubMed
go back to reference Bubenikova-Valesova V, Kacer P, Syslova K, Rambousek L, Janovsky M, Schutova B et al (2009) Prenatal methamphetamine exposure affects the mesolimbic dopaminergic system and behavior in adult offspring. Int J Dev Neurosci 27:525–530PubMedCrossRef Bubenikova-Valesova V, Kacer P, Syslova K, Rambousek L, Janovsky M, Schutova B et al (2009) Prenatal methamphetamine exposure affects the mesolimbic dopaminergic system and behavior in adult offspring. Int J Dev Neurosci 27:525–530PubMedCrossRef
go back to reference Cadet JL, Krasnova IN (2009) Molecular bases of methamphetamine-induced neurodegeneration. Int Rev Neurobiol 88:101–119PubMedCrossRef Cadet JL, Krasnova IN (2009) Molecular bases of methamphetamine-induced neurodegeneration. Int Rev Neurobiol 88:101–119PubMedCrossRef
go back to reference Cass WA (1997) Decreases in evoked overflow of dopamine in rat striatum after neurotoxic doses of methamphetamine. J Exp Ther 280:105–113 Cass WA (1997) Decreases in evoked overflow of dopamine in rat striatum after neurotoxic doses of methamphetamine. J Exp Ther 280:105–113
go back to reference Cernerud L, Eriksson M, Jonsson B, Steneroth G, Zetterstrom R (1996) Amphetamine addiction during pregnancy: 14-year follow-up of growth and school performance. Acta paediatrica 85:204–208PubMedCrossRef Cernerud L, Eriksson M, Jonsson B, Steneroth G, Zetterstrom R (1996) Amphetamine addiction during pregnancy: 14-year follow-up of growth and school performance. Acta paediatrica 85:204–208PubMedCrossRef
go back to reference Chang L, Smith LM, LoPresti C, Yonekura ML, Kuo J, Walot I, Ernst T (2004) Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure. Psychiatry Res Neuroimaging 132:95–106CrossRef Chang L, Smith LM, LoPresti C, Yonekura ML, Kuo J, Walot I, Ernst T (2004) Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure. Psychiatry Res Neuroimaging 132:95–106CrossRef
go back to reference Chang L, Alicata D, Ernst T, Volkow N (2007) Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction 102:16–32PubMedCrossRef Chang L, Alicata D, Ernst T, Volkow N (2007) Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction 102:16–32PubMedCrossRef
go back to reference Chang L, Cloak C, Jiang CS, Farnham S, Tokeshi B, Buchthal S et al (2009) Altered neurometabolites and motor integration in children exposed to methamphetamine in utero. Neuroimage 48:391–397PubMedCentralPubMedCrossRef Chang L, Cloak C, Jiang CS, Farnham S, Tokeshi B, Buchthal S et al (2009) Altered neurometabolites and motor integration in children exposed to methamphetamine in utero. Neuroimage 48:391–397PubMedCentralPubMedCrossRef
go back to reference Cloak CC, Ernst T, Fujii L, Hedemark B, Chang L (2009) Lower diffusion in white matter of children with prenatal methamphetamine exposure. Neurology 72:2068–2075PubMedCentralPubMedCrossRef Cloak CC, Ernst T, Fujii L, Hedemark B, Chang L (2009) Lower diffusion in white matter of children with prenatal methamphetamine exposure. Neurology 72:2068–2075PubMedCentralPubMedCrossRef
go back to reference Cruickshank CC, Dyer KR (2009) A review of the clinical pharmacology of methamphetamine. Addiction 104:1085–1099PubMedCrossRef Cruickshank CC, Dyer KR (2009) A review of the clinical pharmacology of methamphetamine. Addiction 104:1085–1099PubMedCrossRef
go back to reference Cui C, Sakata Haga H, Ohta KI, Nishida M, Yashiki M, Sawada K, Fukui Y (2006) Histological brain alterations following prenatal methamphetamine exposure in rats. Congenit Anom 46:180–187CrossRef Cui C, Sakata Haga H, Ohta KI, Nishida M, Yashiki M, Sawada K, Fukui Y (2006) Histological brain alterations following prenatal methamphetamine exposure in rats. Congenit Anom 46:180–187CrossRef
go back to reference Degenhardt L, Hall W (2012) Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 375:55–70CrossRef Degenhardt L, Hall W (2012) Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 375:55–70CrossRef
go back to reference Della Grotta S, LaGasse LL, Arria AM, Derauf C, Grant P, Smith LM et al (2010) Patterns of methamphetamine use during pregnancy: results from the Infant Development, Environment, and Lifestyle (IDEAL) Study. Matern Child Health J 14:519–527PubMedCentralPubMedCrossRef Della Grotta S, LaGasse LL, Arria AM, Derauf C, Grant P, Smith LM et al (2010) Patterns of methamphetamine use during pregnancy: results from the Infant Development, Environment, and Lifestyle (IDEAL) Study. Matern Child Health J 14:519–527PubMedCentralPubMedCrossRef
go back to reference Eriksson M, Zetterström R (1994) Amphetamine addiction during pregnancy: 10-year follow-up. Acta Paediatr 83:27–31CrossRef Eriksson M, Zetterström R (1994) Amphetamine addiction during pregnancy: 10-year follow-up. Acta Paediatr 83:27–31CrossRef
go back to reference Eriksson M, Larsson G, Winbladh B, Zetterström R (1978) The influence of amphetamine addiction on pregnancy and the newborn infant. Acta paediatrica Scandinavica 67:95PubMedCrossRef Eriksson M, Larsson G, Winbladh B, Zetterström R (1978) The influence of amphetamine addiction on pregnancy and the newborn infant. Acta paediatrica Scandinavica 67:95PubMedCrossRef
go back to reference Eriksson M, Larsson G, Zetterström R (1981) Amphetamine addiction and pregnancy: ii. pregnancy, delivery and the neonatal period. Socio-medical aspects. Acta Obstet Gynecol Scand 60:253–259PubMedCrossRef Eriksson M, Larsson G, Zetterström R (1981) Amphetamine addiction and pregnancy: ii. pregnancy, delivery and the neonatal period. Socio-medical aspects. Acta Obstet Gynecol Scand 60:253–259PubMedCrossRef
go back to reference Eriksson M, Billing L, Steneroth G, Zetterstrom R (1989) Health and development of 8-Year-old children whose mothers abused amphetamine during pregnancy. Acta Paediatr 78:944–949CrossRef Eriksson M, Billing L, Steneroth G, Zetterstrom R (1989) Health and development of 8-Year-old children whose mothers abused amphetamine during pregnancy. Acta Paediatr 78:944–949CrossRef
go back to reference Eriksson M, Jonsson B, Steneroth G, Zetterström R (1994) Cross-sectional growth of children whose mothers abused amphetamines during pregnancy. Acta Paediatr 83:612–617PubMedCrossRef Eriksson M, Jonsson B, Steneroth G, Zetterström R (1994) Cross-sectional growth of children whose mothers abused amphetamines during pregnancy. Acta Paediatr 83:612–617PubMedCrossRef
go back to reference Eriksson M, Jonsson B, Steneroth G, Zetterström R (2000) Amphetamine abuse during pregnancy: Environmental factors and outcome after 14-15 years. Scand J Public Health 28:154–157PubMedCrossRef Eriksson M, Jonsson B, Steneroth G, Zetterström R (2000) Amphetamine abuse during pregnancy: Environmental factors and outcome after 14-15 years. Scand J Public Health 28:154–157PubMedCrossRef
go back to reference Flames N, Hobert O (2011) Transcriptional control of the terminal fate of monoaminergic neurons. Annu Rev Neurosci 34:153–184PubMedCrossRef Flames N, Hobert O (2011) Transcriptional control of the terminal fate of monoaminergic neurons. Annu Rev Neurosci 34:153–184PubMedCrossRef
go back to reference Frost DO, Cadet JL (2000) Effects of methamphetamine-induced neurotoxicity on the development of neural circuitry: a hypothesis. Brain Res Rev 34:103–118PubMedCrossRef Frost DO, Cadet JL (2000) Effects of methamphetamine-induced neurotoxicity on the development of neural circuitry: a hypothesis. Brain Res Rev 34:103–118PubMedCrossRef
go back to reference Golub M, Costa L, Crofton K, Frank D, Fried P, Gladen B et al (2005) NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of amphetamine and methamphetamine. Birth Defects Res B Dev Reprod Toxicol 74:471–584PubMedCrossRef Golub M, Costa L, Crofton K, Frank D, Fried P, Gladen B et al (2005) NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of amphetamine and methamphetamine. Birth Defects Res B Dev Reprod Toxicol 74:471–584PubMedCrossRef
go back to reference Gomes-da-Silva J, Pérez-Rosado A, Miguel R, Fernández-Ruiz J, Silva M, Tavares MA (2002) Prenatal Exposure to Methamphetamine in the Rat. Ann N Y Acad Sci 965:68–77PubMedCrossRef Gomes-da-Silva J, Pérez-Rosado A, Miguel R, Fernández-Ruiz J, Silva M, Tavares MA (2002) Prenatal Exposure to Methamphetamine in the Rat. Ann N Y Acad Sci 965:68–77PubMedCrossRef
go back to reference Graham D, Amos-Kroohs R, Braun A, Grace C, Schaefer T, Skelton M et al (2011) Long-term receptor alterations from developmental methamphetamine exposure in rats by use of selective pharmacological agonists and antagonists. Neurotoxicol Teratol 33:497–498 Graham D, Amos-Kroohs R, Braun A, Grace C, Schaefer T, Skelton M et al (2011) Long-term receptor alterations from developmental methamphetamine exposure in rats by use of selective pharmacological agonists and antagonists. Neurotoxicol Teratol 33:497–498
go back to reference Graham DL, Amos-Kroohs RM, Braun AA, Grace CE, Schaefer TL, Skelton MR et al (2013) Neonatal (+)-methamphetamine exposure in rats alters adult locomotor responses to dopamine D1 and D2 agonists and to a glutamate NMDA receptor antagonist, but not to serotonin agonists. Int J Neuropsychopharmacol 16:377–391PubMedCrossRef Graham DL, Amos-Kroohs RM, Braun AA, Grace CE, Schaefer TL, Skelton MR et al (2013) Neonatal (+)-methamphetamine exposure in rats alters adult locomotor responses to dopamine D1 and D2 agonists and to a glutamate NMDA receptor antagonist, but not to serotonin agonists. Int J Neuropsychopharmacol 16:377–391PubMedCrossRef
go back to reference Greicius MD, Krasnow B, Reiss AL, Menon V (2003) Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc Natl Acad Sci U S A 100:253–258PubMedCentralPubMedCrossRef Greicius MD, Krasnow B, Reiss AL, Menon V (2003) Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc Natl Acad Sci U S A 100:253–258PubMedCentralPubMedCrossRef
go back to reference Helmich RC, Derikx LC, Bakker M, Scheeringa R, Bloem BR, Toni I (2010) Spatial remapping of cortico-striatal connectivity in Parkinson's disease. Cereb Cortex 20:1175–1186 Helmich RC, Derikx LC, Bakker M, Scheeringa R, Bloem BR, Toni I (2010) Spatial remapping of cortico-striatal connectivity in Parkinson's disease. Cereb Cortex 20:1175–1186
go back to reference Jedynak JP, Uslaner JM, Esteban JA, Robinson TE (2007) Methamphetamine-induced structural plasticity in the dorsal striatum. Eur J Neurosci 25:847–853PubMedCrossRef Jedynak JP, Uslaner JM, Esteban JA, Robinson TE (2007) Methamphetamine-induced structural plasticity in the dorsal striatum. Eur J Neurosci 25:847–853PubMedCrossRef
go back to reference Jeng W, Wong AW, Ting-A-Kee R, Wells PG (2005) Methamphetamine-enhanced embryonic oxidative DNA damage and neurodevelopmental deficits. Free Radic Biol Med 39:317–326PubMedCrossRef Jeng W, Wong AW, Ting-A-Kee R, Wells PG (2005) Methamphetamine-enhanced embryonic oxidative DNA damage and neurodevelopmental deficits. Free Radic Biol Med 39:317–326PubMedCrossRef
go back to reference Kaewsuk S, Sae-ung K, Phansuwan-Pujito P, Govitrapong P (2009) Melatonin attenuates methamphetamine-induced reduction of tyrosine hydroxylase, synaptophysin and growth-associated protein-43 levels in the neonatal rat brain. Neurochem Int 55:397–405PubMedCrossRef Kaewsuk S, Sae-ung K, Phansuwan-Pujito P, Govitrapong P (2009) Melatonin attenuates methamphetamine-induced reduction of tyrosine hydroxylase, synaptophysin and growth-associated protein-43 levels in the neonatal rat brain. Neurochem Int 55:397–405PubMedCrossRef
go back to reference Kaltenbach KA, Finnegan LP (1993) Studies of prenatal drug exposure and environmental research issues: the benefits of integrating research within a treatment program. NIDA Res Monogr 117:259–259 Kaltenbach KA, Finnegan LP (1993) Studies of prenatal drug exposure and environmental research issues: the benefits of integrating research within a treatment program. NIDA Res Monogr 117:259–259
go back to reference Khoshbouei H, Wang H, Lechleiter JD, Javitch JA, Galli A (2003) Amphetamine-induced dopamine efflux. A voltage-sensitive and intracellular Na + -dependent mechanism. J Biol Chem 278:12070PubMedCrossRef Khoshbouei H, Wang H, Lechleiter JD, Javitch JA, Galli A (2003) Amphetamine-induced dopamine efflux. A voltage-sensitive and intracellular Na + -dependent mechanism. J Biol Chem 278:12070PubMedCrossRef
go back to reference Kreis R, Ernst T, Ross BD (1993) Absolute quantitation of water and metabolites in the human brain. II: metabolite concentrations. J Magn Reson 102:9–19CrossRef Kreis R, Ernst T, Ross BD (1993) Absolute quantitation of water and metabolites in the human brain. II: metabolite concentrations. J Magn Reson 102:9–19CrossRef
go back to reference LaGasse LL, Wouldes T, Newman E, Smith LM, Shah RZ, Derauf C et al (2011) Prenatal methamphetamine exposure and neonatal neurobehavioral outcome in the USA and New Zealand. Neurotoxicol Teratol 33:166–175PubMedCentralPubMedCrossRef LaGasse LL, Wouldes T, Newman E, Smith LM, Shah RZ, Derauf C et al (2011) Prenatal methamphetamine exposure and neonatal neurobehavioral outcome in the USA and New Zealand. Neurotoxicol Teratol 33:166–175PubMedCentralPubMedCrossRef
go back to reference LaGasse LL, Derauf C, Smith LM, Newman E, Shah R, Neal C et al (2012) Prenatal methamphetamine exposure and childhood behavior problems at 3 and 5 years of age. Pediatrics 129:681–688PubMedCentralPubMedCrossRef LaGasse LL, Derauf C, Smith LM, Newman E, Shah R, Neal C et al (2012) Prenatal methamphetamine exposure and childhood behavior problems at 3 and 5 years of age. Pediatrics 129:681–688PubMedCentralPubMedCrossRef
go back to reference Lewis SJ, Dove A, Robbins TW, Barker RA, Owen AM (2004) Striatal contributions to working memory: a functional magnetic resonance imaging study in humans. Eur J Neurosci 19:755–760PubMedCrossRef Lewis SJ, Dove A, Robbins TW, Barker RA, Owen AM (2004) Striatal contributions to working memory: a functional magnetic resonance imaging study in humans. Eur J Neurosci 19:755–760PubMedCrossRef
go back to reference Little BB, Snell LM, Gilstrap LC (1988) Methamphetamine abuse during pregnancy: outcome and fetal effects. Obstet Gynecol 72:541–544PubMed Little BB, Snell LM, Gilstrap LC (1988) Methamphetamine abuse during pregnancy: outcome and fetal effects. Obstet Gynecol 72:541–544PubMed
go back to reference Lu LH, Johnson A, O’Hare ED, Bookheimer SY, Smith LM, O’Connor MJ, Sowell ER (2009) Effects of prenatal methamphetamine exposure on verbal memory revealed with fMRI. J Dev Behav Pediatr 30:185PubMedCentralPubMedCrossRef Lu LH, Johnson A, O’Hare ED, Bookheimer SY, Smith LM, O’Connor MJ, Sowell ER (2009) Effects of prenatal methamphetamine exposure on verbal memory revealed with fMRI. J Dev Behav Pediatr 30:185PubMedCentralPubMedCrossRef
go back to reference Maisto SA, McKay JR, Connors GJ (1990) Self-report issues in substance abuse: State of the art and future directions. Behavioral Assessment 12:117–134 Maisto SA, McKay JR, Connors GJ (1990) Self-report issues in substance abuse: State of the art and future directions. Behavioral Assessment 12:117–134
go back to reference McKetin R, Kozel N, Douglas J et al (2008) The rise of methamphetamine in Southeast and East Asia. Drug and Alcohol Review 27:220–228PubMedCrossRef McKetin R, Kozel N, Douglas J et al (2008) The rise of methamphetamine in Southeast and East Asia. Drug and Alcohol Review 27:220–228PubMedCrossRef
go back to reference Melo P, Moreno VZ, Vázquez SP, Pinazo-Durán MD, Tavares MA (2006) Myelination changes in the rat optic nerve after prenatal exposure to methamphetamine. Brain Res 1106:21–29PubMedCrossRef Melo P, Moreno VZ, Vázquez SP, Pinazo-Durán MD, Tavares MA (2006) Myelination changes in the rat optic nerve after prenatal exposure to methamphetamine. Brain Res 1106:21–29PubMedCrossRef
go back to reference Substance Abuse and Mental Health Services Administration (2010) Treatment episode data set (TEDS): 1998–2008. State admissions to substance abuse treatment services. DASIS Series: S-55 (HHS Publication No. SMA 10-4613). Rockville, MD: Author Substance Abuse and Mental Health Services Administration (2010) Treatment episode data set (TEDS): 1998–2008. State admissions to substance abuse treatment services. DASIS Series: S-55 (HHS Publication No. SMA 10-4613). Rockville, MD: Author
go back to reference Meredith CW, Jaffe C, Ang-Lee K, Saxon AJ (2005) Implications of chronic methamphetamine use: A literature review. Harv Rev Psychiatry 13:141–154PubMedCrossRef Meredith CW, Jaffe C, Ang-Lee K, Saxon AJ (2005) Implications of chronic methamphetamine use: A literature review. Harv Rev Psychiatry 13:141–154PubMedCrossRef
go back to reference Morrow BA, Roth RH, Redmond DE, Elsworth JD (2011) Impact of methamphetamine on dopamine neurons in primates is dependent on age: implications for development of Parkinson’s disease. Neurosci 189:277–285CrossRef Morrow BA, Roth RH, Redmond DE, Elsworth JD (2011) Impact of methamphetamine on dopamine neurons in primates is dependent on age: implications for development of Parkinson’s disease. Neurosci 189:277–285CrossRef
go back to reference Nguyen D, Smith LM, LaGasse LL, Derauf C, Grant P, Shah R et al (2010) Intrauterine growth of infants exposed to prenatal methamphetamine: results from the infant development, environment, and lifestyle study. J Pediatr 157:337–339PubMedCentralPubMedCrossRef Nguyen D, Smith LM, LaGasse LL, Derauf C, Grant P, Shah R et al (2010) Intrauterine growth of infants exposed to prenatal methamphetamine: results from the infant development, environment, and lifestyle study. J Pediatr 157:337–339PubMedCentralPubMedCrossRef
go back to reference Nordahl TE, Salo R, Leamon M (2003) Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: A review. J Neuropsychiatry Clin Neurosci 15:317–325PubMedCrossRef Nordahl TE, Salo R, Leamon M (2003) Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: A review. J Neuropsychiatry Clin Neurosci 15:317–325PubMedCrossRef
go back to reference Ondersma SJ, Simpson SM, Brestan EV, Ward M (2000) Prenatal drug exposure and social policy: the search for an appropriate response. Child Maltreat 5:93–108PubMedCrossRef Ondersma SJ, Simpson SM, Brestan EV, Ward M (2000) Prenatal drug exposure and social policy: the search for an appropriate response. Child Maltreat 5:93–108PubMedCrossRef
go back to reference Oro AS, Dixon SD (1987) Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates. J Pediatr 111:571–578PubMedCrossRef Oro AS, Dixon SD (1987) Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates. J Pediatr 111:571–578PubMedCrossRef
go back to reference Poland ML, Dombrowski MP, Ager JW, Sokol RJ (1993) Punishing pregnant drug users: enhancing the flight from care. Drug Alcohol Depend 31:199–203PubMedCrossRef Poland ML, Dombrowski MP, Ager JW, Sokol RJ (1993) Punishing pregnant drug users: enhancing the flight from care. Drug Alcohol Depend 31:199–203PubMedCrossRef
go back to reference Roberts S, Nuru-Jeter A (2010) Women’s perspectives on screening for alcohol and drug use in prenatal care. Women Health Iss 20:193–200CrossRef Roberts S, Nuru-Jeter A (2010) Women’s perspectives on screening for alcohol and drug use in prenatal care. Women Health Iss 20:193–200CrossRef
go back to reference Roussotte FF, Bramen JE, Nunez SC, Quandt LC, Smith L, O’Connor MJ et al (2011) Abnormal brain activation during working memory in children with prenatal exposure to drugs of abuse: the effects of methamphetamine, alcohol, and polydrug exposure. NeuroImage 54:3067–3075PubMedCrossRef Roussotte FF, Bramen JE, Nunez SC, Quandt LC, Smith L, O’Connor MJ et al (2011) Abnormal brain activation during working memory in children with prenatal exposure to drugs of abuse: the effects of methamphetamine, alcohol, and polydrug exposure. NeuroImage 54:3067–3075PubMedCrossRef
go back to reference Schmitz Y, Lee CJ, Schmauss C, Gonon F, Sulzer D (2001) Amphetamine distorts stimulation-dependent dopamine overflow: effects on D2 autoreceptors, transporters, and synaptic vesicle stores. J Neurosci 21:5916–5924PubMed Schmitz Y, Lee CJ, Schmauss C, Gonon F, Sulzer D (2001) Amphetamine distorts stimulation-dependent dopamine overflow: effects on D2 autoreceptors, transporters, and synaptic vesicle stores. J Neurosci 21:5916–5924PubMed
go back to reference Scott JC, Woods SP, Matt GE, Meyer RA, Heaton RK, Atkinson JH, Grant I (2007) Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol Rev 17:275–297PubMedCrossRef Scott JC, Woods SP, Matt GE, Meyer RA, Heaton RK, Atkinson JH, Grant I (2007) Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol Rev 17:275–297PubMedCrossRef
go back to reference Semple SJ, Grant I, Patterson TL (2005) Female methamphetamine users: social characteristics and sexual risk behavior. Women & Health 40:35–50CrossRef Semple SJ, Grant I, Patterson TL (2005) Female methamphetamine users: social characteristics and sexual risk behavior. Women & Health 40:35–50CrossRef
go back to reference Šlamberová R, Pometlová M, Charousová P (2006) Postnatal development of rat pups is altered by prenatal methamphetamine exposure. Prog Neuropsychopharmacol Biol Psychiatry 30:82–88PubMedCrossRef Šlamberová R, Pometlová M, Charousová P (2006) Postnatal development of rat pups is altered by prenatal methamphetamine exposure. Prog Neuropsychopharmacol Biol Psychiatry 30:82–88PubMedCrossRef
go back to reference Smith LM, Chang L, Yonekura ML, Grob C, Osborn D, Ernst T (2001) Brain proton magnetic resonance spectroscopy in children exposed to methamphetamine in utero. Neurol 57:255–260CrossRef Smith LM, Chang L, Yonekura ML, Grob C, Osborn D, Ernst T (2001) Brain proton magnetic resonance spectroscopy in children exposed to methamphetamine in utero. Neurol 57:255–260CrossRef
go back to reference Smith LM, LaGasse LL, Derauf C, Grant P, Shah R, Arria A et al (2006) The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics 118:1149–1156PubMedCrossRef Smith LM, LaGasse LL, Derauf C, Grant P, Shah R, Arria A et al (2006) The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics 118:1149–1156PubMedCrossRef
go back to reference Smith DK, Johnson AB, Pears KC, Fisher PA, DeGarmo DS (2007) Child maltreatment and foster care: unpacking the effects of prenatal and postnatal parental substance use. Child Maltreat 12:150–160PubMedCrossRef Smith DK, Johnson AB, Pears KC, Fisher PA, DeGarmo DS (2007) Child maltreatment and foster care: unpacking the effects of prenatal and postnatal parental substance use. Child Maltreat 12:150–160PubMedCrossRef
go back to reference Smith LM, LaGasse LL, Derauf C, Grant P, Shah R, Arria A et al (2008) Prenatal methamphetamine use and neonatal neurobehavioral outcome. Neurotoxicol Teratol 30:20–28 Smith LM, LaGasse LL, Derauf C, Grant P, Shah R, Arria A et al (2008) Prenatal methamphetamine use and neonatal neurobehavioral outcome. Neurotoxicol Teratol 30:20–28
go back to reference Smith LM, LaGasse LL, Derauf C, Newman E, Shah R, Haning W et al (2011) Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine. Neurotoxicol Teratol 33:176–184PubMedCentralPubMedCrossRef Smith LM, LaGasse LL, Derauf C, Newman E, Shah R, Haning W et al (2011) Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine. Neurotoxicol Teratol 33:176–184PubMedCentralPubMedCrossRef
go back to reference Sowell ER, Peterson BS, Thompson PM, Welcome SE, Henkenius AL, Toga AW (2003) Mapping cortical change across the human life span. Nat Neurosci 6:309–315PubMedCrossRef Sowell ER, Peterson BS, Thompson PM, Welcome SE, Henkenius AL, Toga AW (2003) Mapping cortical change across the human life span. Nat Neurosci 6:309–315PubMedCrossRef
go back to reference Sowell ER, Leow AD, Bookheimer SY, Smith LM, O’Connor MJ, Kan E et al (2010) Differentiating prenatal exposure to methamphetamine and alcohol versus alcohol and not methamphetamine using tensor-based brain morphometry and discriminant analysis. J Neurosci 30:3876–3885PubMedCentralPubMedCrossRef Sowell ER, Leow AD, Bookheimer SY, Smith LM, O’Connor MJ, Kan E et al (2010) Differentiating prenatal exposure to methamphetamine and alcohol versus alcohol and not methamphetamine using tensor-based brain morphometry and discriminant analysis. J Neurosci 30:3876–3885PubMedCentralPubMedCrossRef
go back to reference Stanwood GD, Levitt P (2004) Drug exposure early in life: functional repercussions of changing neuropharmacology during sensitive periods of brain development. Curr Opin Pharmacol 4:65–71PubMedCrossRef Stanwood GD, Levitt P (2004) Drug exposure early in life: functional repercussions of changing neuropharmacology during sensitive periods of brain development. Curr Opin Pharmacol 4:65–71PubMedCrossRef
go back to reference Sulzer D, Sonders MS, Poulsen NW, Galli A (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 75:406–433PubMedCrossRef Sulzer D, Sonders MS, Poulsen NW, Galli A (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 75:406–433PubMedCrossRef
go back to reference Suzuki T, Mizuo K, Nakazawa H, Funae Y, Fushiki S, Fukushima S et al (2003) Prenatal and neonatal exposure to bisphenol-A enhances the central dopamine D1 receptor-mediated action in mice: enhancement of the methamphetamine-induced abuse state. Neurosci 117:639–644CrossRef Suzuki T, Mizuo K, Nakazawa H, Funae Y, Fushiki S, Fukushima S et al (2003) Prenatal and neonatal exposure to bisphenol-A enhances the central dopamine D1 receptor-mediated action in mice: enhancement of the methamphetamine-induced abuse state. Neurosci 117:639–644CrossRef
go back to reference Terplan M, Smith EJ, Glavin SH (2010) Trends in injection drug use among pregnant women admitted into drug treatment: 1994–2006. J Womens Health 19:499–505CrossRef Terplan M, Smith EJ, Glavin SH (2010) Trends in injection drug use among pregnant women admitted into drug treatment: 1994–2006. J Womens Health 19:499–505CrossRef
go back to reference Thompson BL, Levitt P, Stanwood GD (2009) Prenatal exposure to drugs: effects on brain development and implications for policy and education. Nat Rev Neurosci 10:303–312PubMedCentralPubMedCrossRef Thompson BL, Levitt P, Stanwood GD (2009) Prenatal exposure to drugs: effects on brain development and implications for policy and education. Nat Rev Neurosci 10:303–312PubMedCentralPubMedCrossRef
go back to reference Twomey J, LaGasse L, Derauf C, Newman E, Shah R, Smith L et al (2013) Prenatal methamphetamine exposure, home environment, and primary caregiver risk factors predict child behavioral problems at 5 Years. Am J Orthopsychiatry 83:64–72PubMedCentralPubMedCrossRef Twomey J, LaGasse L, Derauf C, Newman E, Shah R, Smith L et al (2013) Prenatal methamphetamine exposure, home environment, and primary caregiver risk factors predict child behavioral problems at 5 Years. Am J Orthopsychiatry 83:64–72PubMedCentralPubMedCrossRef
go back to reference United Nations Office on Drugs, & Crime (2010) World Drug Report 2010. United Nations Publications United Nations Office on Drugs, & Crime (2010) World Drug Report 2010. United Nations Publications
go back to reference United Nations Office on Drugs, and Crime (2013) World Drug Report 2013. United Nations Publications United Nations Office on Drugs, and Crime (2013) World Drug Report 2013. United Nations Publications
go back to reference Vaccarino FM, Ment LR (2004) Injury and repair in developing brain. Arch Dis Child Fetal Neonatal Ed 89:190–192CrossRef Vaccarino FM, Ment LR (2004) Injury and repair in developing brain. Arch Dis Child Fetal Neonatal Ed 89:190–192CrossRef
go back to reference Weiss K, Melkus G, Jakob PM, Faber C (2009) Quantitative in vivo (1)H spectroscopic imaging of metabolites in the early postnatal mouse brain at 17.6 T. MAGMA 22:53–62PubMedCrossRef Weiss K, Melkus G, Jakob PM, Faber C (2009) Quantitative in vivo (1)H spectroscopic imaging of metabolites in the early postnatal mouse brain at 17.6 T. MAGMA 22:53–62PubMedCrossRef
go back to reference Won L, Bubula N, McCoy H, Heller A (2001) Methamphetamine concentrations in fetal and maternal brain following prenatal exposure. Neurotoxicol Teratol 23:349–354PubMedCrossRef Won L, Bubula N, McCoy H, Heller A (2001) Methamphetamine concentrations in fetal and maternal brain following prenatal exposure. Neurotoxicol Teratol 23:349–354PubMedCrossRef
go back to reference Wouldes TA, LaGasse LL, Derauf C, Newman E, Shah R, Smith LM et al (2013) Co-morbidity of substance use disorder and psychopathology in women who use methamphetamine during pregnancy in the US and New Zealand. Drug Alcohol Depend 127:101–107PubMedCentralPubMedCrossRef Wouldes TA, LaGasse LL, Derauf C, Newman E, Shah R, Smith LM et al (2013) Co-morbidity of substance use disorder and psychopathology in women who use methamphetamine during pregnancy in the US and New Zealand. Drug Alcohol Depend 127:101–107PubMedCentralPubMedCrossRef
Metadata
Title
Effects of prenatal methamphetamine exposure: a review of cognitive and neuroimaging studies
Authors
Maja A. Kwiatkowski
Annerine Roos
Dan J. Stein
Kevin G. F. Thomas
Kirsty Donald
Publication date
01-06-2014
Publisher
Springer US
Published in
Metabolic Brain Disease / Issue 2/2014
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-013-9470-7

Other articles of this Issue 2/2014

Metabolic Brain Disease 2/2014 Go to the issue